- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Former NIH Director Bernadine Healy Dies
8 August 2011 4:51 pm
Bernadine Healy, a cardiologist who was the first woman to direct the National Institutes of Health (NIH) from 1991 to 1993, died on Saturday from brain cancer.
Appointed by President George H. W. Bush, Healy was an outspoken NIH director during a tumultuous period. She proposed the Women's Health Initiative, a $625-million study that followed more than 140,000 women in part to learn about the health effects of estrogen replacement therapy. Although some researchers questioned the cost and top-down management of the initiative, it proved its worth a decade later by showing that taking estrogen raises a woman's risk of stroke, heart disease, and breast cancer.
Healy battled a powerful member of Congress, Representative John Dingell (D-MI), over scientific misconduct investigations involving Nobelist David Baltimore's lab and Robert Gallo's role in discovering the AIDS virus. James Watson, the first director of the Human Genome Project, quit after clashing with Healy. But she made a smart hire by replacing him with Francis Collins, who is now NIH director.
Healy crafted the first strategic plan for NIH, which went nowhere after meeting resistance. She also oversaw the transfer of mental health, alcoholism, and drug abuse institutes from another agency to NIH. And she became caught up in a battle over fetal tissue research; as an administration appointee, she supported Bush's ban before Congress.
"She was a very talented, highly intelligent, energetic woman who rubbed some people the wrong way, but when she believed in something she was extremely effective in getting it implemented," says Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
Harvard Medical School's David Korn, who was dean of the Stanford medical school at the time, says that Healy was "in a difficult position" as one of few women in leadership posts at NIH. Her background as a cardiologist and desire to "corporatize" NIH drew "hostility" from basic scientists who worried about their funding, Korn says. Yet the strategic plan was a "preview" of what a subsequent NIH director, Elias Zerhouni, did when he created an office to analyze NIH's portfolio, Korn says. "I think it was very thoughtful and forethinking of her," Korn says.
President Bill Clinton did not retain Healy, who later became dean of Ohio State University's medical school. She also ran unsuccessfully for the Senate and led the Red Cross during the 9/11 terrorist attacks. She worked as a health editor and columnist for US News and World Report until last year when a brain tumor that was removed in 1999 recurred. She was 67 when she died.